1-2 of 2
Jana Pachlopnik Schmid
Close
Sort by
Journal Articles

Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Matthias Felber, Colin G. Steward, Karim Kentouche, Anders Fasth, Robert F. Wynn, Ulrike Zeilhofer, Veronika Haunerdinger, Benjamin Volkmer, Seraina Prader, Bernd Gruhn, Stephan Ehl, Kai Lehmberg, Daniel Müller, Andrew R. Gennery, Michael H. Albert, Fabian Hauck, Kanchan Rao, Paul Veys, Moustapha Hassan, Arjan C. Lankester, Jana Pachlopnik Schmid, Mathias M. Hauri-Hohl, Tayfun Güngör
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1998–2010.
https://doi.org/10.1182/bloodadvances.2020001748
Published: 2020
Includes: Supplemental data
Journal Articles

Lymphadenopathy driven by TCR-V γ 8V δ 1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome

Clinical Trials & Observations
Stefano Vavassori, Jacob D. Galson, Johannes Trück, Anke van den Berg, Rienk Y. J. Tamminga, Aude Magerus-Chatinet, Olivier Pellé, Ulrike Camenisch Gross, Ewerton Marques Maggio, Seraina Prader, Lennart Opitz, Ursina Nüesch, Andrea Mauracher, Benjamin Volkmer, Oliver Speer, Luzia Suda, Benno Röthlisberger, Dieter Robert Zimmermann, Rouven Müller, Arjan Diepstra, Lydia Visser, Eugenia Haralambieva, Bénédicte Neven, Frédéric Rieux-Laucat, Jana Pachlopnik Schmid
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1101–1106.
https://doi.org/10.1182/bloodadvances.2017006411
Published: 2017
Includes: Supplemental data